{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T21:19:32Z","timestamp":1791148772908,"version":"4.1.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1016\/j.lfs.2013.11.010","type":"journal-article","created":{"date-parts":[[2013,11,21]],"date-time":"2013-11-21T16:46:10Z","timestamp":1385052370000},"page":"115-121","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["Novel GPR40 agonist AS2575959 exhibits glucose metabolism improvement and synergistic effect with sitagliptin on insulin and incretin secretion"],"prefix":"10.1016","volume":"94","author":[{"given":"Hirotsugu","family":"Tanaka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeru","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideaki","family":"Minoura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Negoro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiyoshi","family":"Shimaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teruhiko","family":"Shimokawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Shibasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2013.11.010_bb0160","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/S0140-6736(98)07037-8","article-title":"Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)","volume":"352","author":"UK Prospective Diabetes Study (UKPDS) Group","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.lfs.2013.11.010_bb0010","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1517\/14656560903530683","article-title":"Combination therapy with mitiglinide and voglibose improves glycemic control in type 2 diabetic patients on hemodialysis","volume":"11","author":"Abe","year":"2010","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.lfs.2013.11.010_bb0015","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/j.1463-1326.2010.01334.x","article-title":"Efficacy and safety of treatment with sitagliptin or glimepiride in patients with type 2 diabetes inadequately controlled on metformin monotherapy: a randomized, double-blind, non-inferiority trial","volume":"13","author":"Arechavaleta","year":"2011","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.lfs.2013.11.010_bb0020","doi-asserted-by":"crossref","first-page":"11303","DOI":"10.1074\/jbc.M211495200","article-title":"The orphan G protein-coupled receptor GPR40 is activated by medium and long chain fatty acids","volume":"278","author":"Briscoe","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.lfs.2013.11.010_bb0025","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/S0140-6736(11)61879-5","article-title":"TAK-875 versus placebo or glimepiride in type 2 diabetes mellitus: a phase 2, randomised, double-blind, placebo-controlled trial","volume":"379","author":"Burant","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.lfs.2013.11.010_bb0165","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1007\/s00125-013-2905-1","volume":"56","author":"Charbonnel","year":"2013","journal-title":"Diabetologia"},{"key":"10.1016\/j.lfs.2013.11.010_bb0035","doi-asserted-by":"crossref","first-page":"7061","DOI":"10.1021\/jm8010178","article-title":"Discovery of potent and selective agonists for the free fatty acid receptor 1 (FFA(1)\/GPR40), a potential target for the treatment of type II diabetes","volume":"51","author":"Christiansen","year":"2008","journal-title":"J Med Chem"},{"key":"10.1016\/j.lfs.2013.11.010_bb0040","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/j.1753-0407.2012.00223.x","article-title":"Efficacy and safety of sitagliptin added to ongoing metformin and rosiglitazone combination therapy in a randomized placebo-controlled 54-week trial in patients with type 2 diabetes","volume":"5","author":"Dobs","year":"2013","journal-title":"J Diabetes"},{"key":"10.1016\/j.lfs.2013.11.010_bb0045","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.2337\/diacare.26.10.2929","article-title":"Enhancing incretin action for the treatment of type 2 diabetes","volume":"26","author":"Drucker","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/j.lfs.2013.11.010_bb0170","doi-asserted-by":"crossref","first-page":"3316","DOI":"10.2337\/db13-0822","article-title":"Incretin action in the pancreas: potential promise, possible perils, and pathological pitfalls","volume":"62","author":"Drucker","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.lfs.2013.11.010_bb0055","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.2337\/db08-0307","article-title":"Gpr40 is expressed in enteroendocrine cells and mediates free fatty acid stimulation of incretin secretion","volume":"57","author":"Edfalk","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.lfs.2013.11.010_bb0060","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1111\/j.1742-1241.2010.02382.x","article-title":"Sitagliptin: review of preclinical and clinical data regarding incidence of pancreatitis","volume":"64","author":"Engel","year":"2010","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.lfs.2013.11.010_bb0065","doi-asserted-by":"crossref","first-page":"E670","DOI":"10.1152\/ajpendo.00035.2005","article-title":"Oleic acid interacts with GPR40 to induce Ca2+ signaling in rat islet beta-cells: mediation by PLC and L-type Ca2+ channel and link to insulin release","volume":"289","author":"Fujiwara","year":"2005","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.lfs.2013.11.010_bb0070","doi-asserted-by":"crossref","first-page":"4612","DOI":"10.1210\/jc.2006-1009","article-title":"Effect of single oral doses of sitagliptin, a dipeptidyl peptidase-4 inhibitor, on incretin and plasma glucose levels after an oral glucose tolerance test in patients with type 2 diabetes","volume":"91","author":"Herman","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.lfs.2013.11.010_bb0075","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/nature01478","article-title":"Free fatty acids regulate insulin secretion from pancreatic beta cells through GPR40","volume":"422","author":"Itoh","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.lfs.2013.11.010_bb0080","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/j.1463-1326.2010.01197.x","article-title":"Efficacy and safety of sitagliptin monotherapy compared with voglibose in Japanese patients with type 2 diabetes: a randomized, double-blind trial","volume":"12","author":"Iwamoto","year":"2010","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.lfs.2013.11.010_bb0085","doi-asserted-by":"crossref","first-page":"245","DOI":"10.2337\/dc12-0872","article-title":"Randomized, double-blind, dose-ranging study of TAK-875, a novel GPR40 agonist, in Japanese patients with inadequately controlled type 2 diabetes","volume":"36","author":"Kaku","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.lfs.2013.11.010_bb0090","doi-asserted-by":"crossref","first-page":"e27270","DOI":"10.1371\/journal.pone.0027270","article-title":"AMG 837: a novel GPR40\/FFA1 agonist that enhances insulin secretion and lowers glucose levels in rodents","volume":"6","author":"Lin","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2013.11.010_bb0095","doi-asserted-by":"crossref","first-page":"e46300","DOI":"10.1371\/journal.pone.0046300","article-title":"A potent class of GPR40 full agonists engages the enteroinsular axis to promote glucose control in rodents","volume":"7","author":"Luo","year":"2012","journal-title":"PLoS One"},{"issue":"Suppl. 3","key":"10.1016\/j.lfs.2013.11.010_bb0175","doi-asserted-by":"crossref","first-page":"18","DOI":"10.2337\/diacare.13.3.18","article-title":"Sulfonylureas. Why, which, and how?","volume":"13","author":"Melander","year":"1990","journal-title":"Diabetes Care"},{"key":"10.1016\/j.lfs.2013.11.010_bb0105","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.2337\/db08-1233","article-title":"Overexpression of GPR40 in pancreatic beta-cells augments glucose-stimulated insulin secretion and improves glucose tolerance in normal and diabetic mice","volume":"58","author":"Nagasumi","year":"2009","journal-title":"Diabetes"},{"issue":"Suppl. 1","key":"10.1016\/j.lfs.2013.11.010_bb0110","first-page":"25","article-title":"Acute and chronic effects of sulfonylurea drugs on pancreatic islet function in man","volume":"7","author":"Pfeifer","year":"1984","journal-title":"Diabetes Care"},{"issue":"Suppl. 2","key":"10.1016\/j.lfs.2013.11.010_bb0115","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1007\/s001250051395","article-title":"Signal transduction mechanisms in nutrient-induced insulin secretion","volume":"40","author":"Prentki","year":"1997","journal-title":"Diabetologia"},{"key":"10.1016\/j.lfs.2013.11.010_bb0120","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1475-2840-12-35","article-title":"Effects of sitagliptin beyond glycemic control: focus on quality of life","volume":"12","author":"Sakamoto","year":"2013","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.lfs.2013.11.010_bb0125","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0168-8227(03)00169-4","article-title":"Improvement of insulin resistance by a new insulin secretagogue, nateglinide \u2014 analysis based on the homeostasis model","volume":"62","author":"Shiba","year":"2003","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.lfs.2013.11.010_bb0130","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.2337\/db08-0130","article-title":"Selective small-molecule agonists of G protein-coupled receptor 40 promote glucose-dependent insulin secretion and reduce blood glucose in mice","volume":"57","author":"Tan","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.lfs.2013.11.010_bb0180","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1124\/jpet.113.206466","article-title":"Chronic treatment with novel GPR40 agonists improve whole-body glucose metabolism based on the glucose-dependent insulin secretion","volume":"346","author":"Tanaka","year":"2013","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.lfs.2013.11.010_bb0140","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/350516a0","article-title":"Activation of the beta 1 isozyme of phospholipase C by alpha subunits of the Gq class of G proteins","volume":"350","author":"Taylor","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.lfs.2013.11.010_bb0145","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1124\/jpet.111.183772","article-title":"TAK-875, an orally available G protein-coupled receptor 40\/free fatty acid receptor 1 agonist, enhances glucose-dependent insulin secretion and improves both postprandial and fasting hyperglycemia in type 2 diabetic rats","volume":"339","author":"Tsujihata","year":"2011","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.lfs.2013.11.010_bb0150","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.mce.2013.01.009","article-title":"Activation of FFA1 mediates GLP-1 secretion in mice. Evidence for allosterism at FFA1","volume":"369","author":"Xiong","year":"2013","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.lfs.2013.11.010_bb0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cellsig.2009.09.032","article-title":"New insights into the role of cAMP in the production and function of the incretin hormone glucagon-like peptide-1 (GLP-1)","volume":"22","author":"Yu","year":"2010","journal-title":"Cell Signal"}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320513007091?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320513007091?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,8]],"date-time":"2018-10-08T17:20:57Z","timestamp":1539019257000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320513007091"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["S0024320513007091"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2013.11.010","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.726761847.793523449","asserted-by":"object"}]},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel GPR40 agonist AS2575959 exhibits glucose metabolism improvement and synergistic effect with sitagliptin on insulin and incretin secretion","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2013.11.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}